Short interest for Sanara MedTech gives investors a sense of the degree to which investors are betting on the decline of Sanara MedTech's stock. Short interest data is updated every two weeks.

Sanara MedTech Stock (NASDAQ:SMTI), Short Interest Report

Sanara MedTech

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

AIRT

ASYS

BLIN

BSQR

CCIV

CCNC

CLBS

CLEU

CLGN

COWN

CPSH

EBON

EDRY

FDMT

FOLD

FTFT

GMBL

Grindrod Shipping Holdings Ltd Ordinary Shares

GRIN

HUBS

IFMK

ILMN

IMGN

INPX

LGHL

LIZI

LLIT

NEXI

NOVN

ONCR

PRTA

QUIK

RELI

RKDA

SALM

SMTI

TLIS

TOPS

TRCH

TRVG

TUFN

VCRA

VUZI

WAFU

ZKIN

64 Biggest Movers From Friday

Movers & Shakers

General

AMBO

AMPE

ANCN

ARTL

BMBL

GRNVU

INUV

30 Stocks Moving In Friday&#39;s Mid-Day Session

Eurozone

Commodities

Global

AMBC

DXCM

Following the market opening Friday, the Dow declined 0.09% to 31,402.67, while the NASDAQ fell 0.21% to 13,996.18. The S&amp;P also plunged 0.05% to 3,914.51. 

Leading and Lagging Sectors



Mid-Morning Market Update: US Stock Futures Trend Down; Nasdaq Composite Dips 0.2%

Sanara MedTech Inc

Benchmark analyst Bill Sutherland reiterates Huron Consulting Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HURN#NASDAQ">HURN</a>) with a Buy and maintains $140 price target.

Price Target

Reiteration

Analyst Ratings

HURN

Benchmark Reiterates Buy on Huron Consulting Gr, Maintains $140 Price Target

JP Morgan analyst Tami Zakaria maintains PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) with a Overweight and lowers the price target from $140 to $130.

PCAR

JP Morgan Maintains Overweight on PACCAR, Lowers Price Target to $130

Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) plans to construct a data center in Vietnam to meet legal requirements for local data storage and to cater to increasing demand in one of Asia&#8217;s fastest-growing economies. 
Currently, Alibaba rents server space from Vietnamese state-owned telecommunications companies Viettel and VNPT. 
The arrangement follows Vietnam&#8217;s contentious 2022 law mandating that companies store data within the country—a regulation that sparked resistance from major tech firms like&nbsp;Alphabet Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)&nbsp;Google&nbsp;and&nbsp;Amazon.Com Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), the Nikkei Asia&nbsp;<a target="_blank" href="https://asia.nikkei.com/Business/Technology/Alibaba-to-build-Vietnam-data-center-to-follow-local-storage-law" rel="noreferrer noopener">reports</a>.
Dang Minh Tam, Alibaba Cloud&#8217;s solution architect lead, noted that the company uses colocation services from these state companies to store client data locally. It also maintains backups across its server farms in regions including Taiwan and Singapore.&nbsp;
The move is part of Alibaba&#8217;s strategy to ensure better security and control over its data and potentially reduce costs and liability issues associated with multi-company data management.&nbsp;
Companies including&nbsp;Nvidia Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>),&nbsp;Apple Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), and&nbsp;Lam Research Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) have reached out to Vietnam to diversify their supply chain base amid heightening geopolitical tensions between the US and China.
Lam Research&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/03/37886908/lam-research-eyes-vietnam-to-diversify-supply-chain-away-from-china-report" rel="noreferrer noopener">weighed the supply chain shift</a>&nbsp;to Vietnam, with the Vietnamese government canvassing the former to commit $1 billion to local production efforts.
&nbsp;Apple&nbsp;<a target="_blank" href="https://www.benzinga.com/government/24/04/38460042/apple-strengthens-supply-chain-in-china-while-growing-presence-in-southeast-asia-and-india" rel="noreferrer noopener">suppliers in Vietnam</a>&nbsp;increased by 40% to 35 in 2023.
Meanwhile, Nvidia tapped&nbsp;<a target="_blank" href="https://www.benzinga.com/government/23/12/36171360/whats-going-on-with-nvidia-stock-monday" rel="noreferrer noopener">Vietnamese tech firms</a>&nbsp;for AI development.
Alibaba stock lost over 11% in the last 12 months. Investors can gain exposure to the stock via&nbsp;Invesco Golden Dragon China ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGJ#NASDAQ">PGJ</a>) and&nbsp;Tidal Trust II CoreValues Alpha Greater China Growth ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGRO#NYSE">CGRO</a>).
Price Action: BABA shares are trading higher by 1.28% at $75.78 at the last check on Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors
Alibaba Photo by zhu difeng on Shutterstock

Government

Regulations

Tech

Media

AAPL

AMZN

BABA

CGRO

GOOG

GOOGL

LRCX

NVDA

PowerShares Golden Dragon Halter USX China Portfolio

After Nvidia and Apple, Alibaba Chases Vietnam: New Data Center to Boost Control and Meet Local Laws

JP Morgan analyst Steven Alexopoulos maintains MVB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVBF#NASDAQ">MVBF</a>) with a Overweight and lowers the price target from $28 to $25.

MVBF

JP Morgan Maintains Overweight on MVB Financial, Lowers Price Target to $25

Management

TSLA

Tesla's Top HR Executive Allie Arebalo Has Left The Company

Benchmark analyst Bruce Jackson reiterates NeoGenomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) with a Buy and maintains $18 price target.

Benchmark Reiterates Buy on NeoGenomics, Maintains $18 Price Target

JP Morgan analyst Andrea Teixeira maintains Molson Coors Beverage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) with a Neutral and lowers the price target from $66 to $60.

JP Morgan Maintains Neutral on Molson Coors Beverage, Lowers Price Target to $60

Pseudonymous crypto trader Altcoin Sherpa took to his social media account to share valuable insights on how to interpret <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38528542/bitcoin-dogecoin-shiba-inu-pumped-after-the-last-fomc-meeting-will-history-repeat-on-wedne">weakening support levels</a> in the Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) market.
What Happened: Sherpa uses an analogy of a dropped ball to explain how the first bounce off a support level is typically the strongest, with subsequent bounces becoming progressively weaker. 
He states that the first drop has the best bounce and then there are weaker bounces. He goes on to add that a classic example is Bitcoin at the &#8220;unbreakable&#8221; $6,000 level in 2018.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Today&#39;s <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> post will be on support WEAKENING every time it is touched. I like to use the analogy of a dropped ball. The first time you drop it, it has the best bounce off the ground. Then weaker and weaker bounces after. The classic example of this is <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> at the… <a href="https://t.co/4HVs6uSx3N">pic.twitter.com/4HVs6uSx3N</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1785305011129319878?ref_src=twsrc%5Etfw">April 30, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He also credits fellow trader CryptoCred for the concept of "first test, best test," which highlights the importance of the initial reaction to a support level. The trader suggests that the strongest bounce is often due to a combination of resting orders and late shorters getting caught off guard.
However, as the price revisits the same support level multiple times, the reactions tend to weaken. But zooming out <a href="https://twitter.com/AltcoinSherpa/status/1785305047074525508">reveals</a> that the market is still very bullish. Even a 50% retracement to $40,000 would not necessarily invalidate the overall bullish sentiment, according to Altcoin Sherpa.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is the first real pause we&#39;ve had on the 1W in a long time. Zooming out, we are still very bullish and there are a lot of levels to break before this turns bearish. We could go all the way down to 40k and still be fine IMO. 50% retrace after all that is ok. <a href="https://t.co/wiD6OvA1Y7">pic.twitter.com/wiD6OvA1Y7</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1785305047074525508?ref_src=twsrc%5Etfw">April 30, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He writes, "Those previous buyers are getting their orders filled, and there is less and less support the more times it&#8217;s tapped."  This phenomenon can lead to consolidation at the support level before a potential breakdown.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38500667/raoul-pal-predicts-crypto-to-enter-banana-zone-soon-and-100-trillion-market-cap-within-10-">Raoul Pal Predicts Crypto To Enter &#8216;Banana Zone&#8217; Soon And $100 Trillion Market Cap Within 10 Years</a>
Why It Matters: While this pattern is most observed during liquidation events characterized by long wicks and high volatility, Altcoin Sherpa emphasizes that context matters.
The bouncing ball analogy is more applicable to ranging markets and bearish market structures. In bullish market structures, prices may revisit lows before strongly taking off again, as seen in Bitcoin&#8217;s 2021 rally to $60,000.
The Bitcoin market is currently in a ranging structure with no clear trend on lower time frames. Looking ahead, Altcoin Sherpa believes that bullish catalysts, such as the upcoming election and improving macroeconomic conditions, support remaining long on Bitcoin.
While traders are advised to be prepared for short-term volatility and potentially lower prices, Sherpa suggests avoiding panic selling and maintaining a long-term perspective.
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:&nbsp; <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38499287/ethereums-bottom-against-bitcoin-still-likely-a-few-months-away-predicts-crypto-analyst">Ethereum&#8217;s Bottom Against Bitcoin &#8216;Still Likely A Few Months Away,&#8217; Predicts Crypto Analyst</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

This Trader Sees Bitcoin Dropping To $40,000 And Still Be Fine: 'Expect Lower Prices But Don't Panic Sell'

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRY#NASDAQ">SGRY</a>) with a Buy and maintains $50 price target.

SGRY

Benchmark Reiterates Buy on Surgery Partners, Maintains $50 Price Target

Financial giants have made a conspicuous bearish move on MongoDB. Our analysis of options history for MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) revealed 16 unusual trades.
Delving into the details, we found 31% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 12 were puts, with a value of $508,740, and 4 were calls, valued at $152,105.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $320.0 to $430.0 for MongoDB over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for MongoDB options trades today is 277.09 with a total volume of 397.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for MongoDB's big money trades within a strike price range of $320.0 to $430.0 over the last 30 days.
<h3>MongoDB Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714576609_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$39.35</td>
<td>$39.2</td>
<td>$39.2</td>
<td>$350.00</td>
<td>$78.6K</td>
<td style="text-align: right;">289</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/10/24</td>
<td>$11.45</td>
<td>$10.3</td>
<td>$11.45</td>
<td>$370.00</td>
<td>$58.4K</td>
<td style="text-align: right;">817</td>
<td style="text-align: right;">51</td>
</tr>
<tr>
<td>MDB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$34.3</td>
<td>$32.95</td>
<td>$32.95</td>
<td>$430.00</td>
<td>$56.0K</td>
<td style="text-align: right;">20</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/03/24</td>
<td>$2.0</td>
<td>$1.85</td>
<td>$2.0</td>
<td>$355.00</td>
<td>$47.6K</td>
<td style="text-align: right;">379</td>
<td style="text-align: right;">14</td>
</tr>
<tr>
<td>MDB</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$20.25</td>
<td>$20.0</td>
<td>$20.0</td>
<td>$340.00</td>
<td>$44.0K</td>
<td style="text-align: right;">709</td>
<td style="text-align: right;">24</td>
</tr>
</tbody>
</table>

<h3>About MongoDB</h3>
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
In light of the recent options history for MongoDB, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of MongoDB</h3>
<ul>
<li>Currently trading with a volume of 326,076, the MDB's price is up by 1.77%, now at $371.64. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 29 days.</li>
</ul>
<h3>What The Experts Say On MongoDB</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $446.25.
<ul>
<li>Maintaining their stance, an analyst from Keybanc continues to hold a Overweight rating for MongoDB, targeting a price of $440. </li>
<li>In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $465. </li>
<li>Reflecting concerns, an analyst from Loop Capital lowers its rating to Buy with a new price target of $415.</li>
<li>In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $465. </li>
</ul>
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for MongoDB, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Decoding MongoDB's Options Activity: What's the Big Picture?

Deep-pocketed investors have adopted a bearish approach towards Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PANW usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 40 extraordinary options activities for Palo Alto Networks. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 42% leaning bullish and 55% bearish. Among these notable options, 11 are puts, totaling $1,610,011, and 29 are calls, amounting to $2,759,376.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $200.0 to $410.0 for Palo Alto Networks over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Palo Alto Networks's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Palo Alto Networks's significant trades, within a strike price range of $200.0 to $410.0, over the past month.
<h3>Palo Alto Networks Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714576603_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PANW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$26.85</td>
<td>$26.0</td>
<td>$26.25</td>
<td>$250.00</td>
<td>$866.2K</td>
<td>1.0K</td>
<td style="text-align: right;">330</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$18.7</td>
<td>$18.45</td>
<td>$18.7</td>
<td>$300.00</td>
<td>$591.1K</td>
<td>905</td>
<td style="text-align: right;">320</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$19.85</td>
<td>$19.2</td>
<td>$19.8</td>
<td>$410.00</td>
<td>$435.6K</td>
<td>133</td>
<td style="text-align: right;">220</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$27.4</td>
<td>$27.1</td>
<td>$27.1</td>
<td>$300.00</td>
<td>$235.7K</td>
<td>841</td>
<td style="text-align: right;">135</td>
</tr>
<tr>
<td>PANW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$48.95</td>
<td>$44.4</td>
<td>$44.42</td>
<td>$360.00</td>
<td>$223.1K</td>
<td>214</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>

<h3>About Palo Alto Networks</h3>
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 85,000 customers across the world, including more than three fourths of the Global 2000.
Having examined the options trading patterns of Palo Alto Networks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Palo Alto Networks's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,003,376, with PANW's price down by -1.7%, positioned at $285.95.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 20 days.</li>
</ul>
<h3>Expert Opinions on Palo Alto Networks</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $345.0.
<ul>
<li>An analyst from Oppenheimer has decided to maintain their Outperform rating on Palo Alto Networks, which currently sits at a price target of $330. </li>
<li>An analyst from Keybanc has decided to maintain their Overweight rating on Palo Alto Networks, which currently sits at a price target of $355. </li>
<li>An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $350. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Palo Alto Networks options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

PANW

Behind the Scenes of Palo Alto Networks's Latest Options Trends

Financial giants have made a conspicuous bearish move on UnitedHealth Group. Our analysis of options history for UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) revealed 8 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $99,225, and 6 were calls, valued at $927,065.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $230.0 to $530.0 for UnitedHealth Group over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for UnitedHealth Group's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across UnitedHealth Group's significant trades, within a strike price range of $230.0 to $530.0, over the past month.
<h3>UnitedHealth Group 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714576598_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$83.35</td>
<td>$81.25</td>
<td>$82.1</td>
<td>$410.00</td>
<td>$246.3K</td>
<td>413</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/16/24</td>
<td>$83.05</td>
<td>$81.1</td>
<td>$81.9</td>
<td>$410.00</td>
<td>$245.7K</td>
<td>413</td>
<td style="text-align: right;">60</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$81.6</td>
<td>$79.9</td>
<td>$80.5</td>
<td>$410.00</td>
<td>$241.5K</td>
<td>413</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/21/24</td>
<td>$255.7</td>
<td>$251.45</td>
<td>$253.89</td>
<td>$230.00</td>
<td>$126.9K</td>
<td>13</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$15.8</td>
<td>$15.65</td>
<td>$15.75</td>
<td>$490.00</td>
<td>$53.5K</td>
<td>1.1K</td>
<td style="text-align: right;">37</td>
</tr>
</tbody>
</table>

<h3>About UnitedHealth Group</h3>
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 53 million members globally, including 5 million outside the U.S. as of mid-2023. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Having examined the options trading patterns of UnitedHealth Group, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of UnitedHealth Group</h3>
<ul>
<li>With a volume of 511,160, the price of UNH is up 0.08% at $484.1. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 72 days.</li>
</ul>
<h3>What Analysts Are Saying About UnitedHealth Group</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $551.4.
<ul>
<li>Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for UnitedHealth Group, targeting a price of $571. </li>
<li>An analyst from TD Cowen has decided to maintain their Buy rating on UnitedHealth Group, which currently sits at a price target of $546. </li>
<li>An analyst from Barclays persists with their Overweight rating on UnitedHealth Group, maintaining a target price of $560. </li>
<li>Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for UnitedHealth Group, targeting a price of $525. </li>
<li>Maintaining their stance, an analyst from RBC Capital continues to hold a Outperform rating for UnitedHealth Group, targeting a price of $555. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for UnitedHealth Group with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

A Closer Look at UnitedHealth Group's Options Market Dynamics

JP Morgan analyst John Ivankoe maintains McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) with a Overweight and lowers the price target from $300 to $290.

JP Morgan Maintains Overweight on McDonald's, Lowers Price Target to $290

Mastercard Inc.&nbsp;(NYSE:&nbsp;MA)&nbsp;reported fiscal first-quarter net revenues of $6.35 billion, up 10% year over year and 11% year over year on a neutral currency basis,&nbsp;beating the consensus of&nbsp;<a target="_blank" href="https://investor.mastercard.com/overview/default.aspx" rel="noreferrer noopener">$6.34 billion</a>. Adjusted EPS rose 18% year over year to $3.31, exceeding the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $3.24</a>.
Payment network net revenue rose 7% Y/Y (+8% Y/Y on a currency-neutral basis), led by growth in gross dollar volume (+10% Y/Y), cross-border volume (+18% Y/Y) and switched transactions (+13% Y/Y).&nbsp;
Also&nbsp;Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38337407/mastercards-latest-virtual-card-app-move-to-boost-contactless-payments-analyst-eyes-substantial-grow" rel="noreferrer noopener">Mastercard's&nbsp;Latest Virtual Card App Move to Boost Contactless Payments; Analyst Eyes Substantial Growth Citing Advanced Security and Digital Innovations</a>
Value-added services and solutions net revenue rose 16% and 15% on a currency-neutral basis, driven by continued strong growth in cyber and intelligence solutions and high demand for consulting, marketing, and loyalty solutions.
Total operating expenses increased 5%. Excluding the impact of special items, adjusted operating expenses increased by 9% on a currency-neutral basis, primarily due to higher personnel costs.&nbsp;
The adjusted operating margin expanded 60bps Y/Y to 58.8%.
As of March&nbsp;31, 2024, the&nbsp;company's&nbsp;customers had issued 3.4 billion Mastercard and Maestro branded cards.
During the first quarter of 2024, Mastercard repurchased 4.4&nbsp;million shares for $2.0&nbsp;billion and paid $616 million in dividends.&nbsp;
As of March 31, 2024, cash and cash equivalents stood at $9.5 billion.
"Our momentum continued this quarter, as we delivered strong revenue and earnings growth powered by healthy consumer spending, strong cross-border volume growth of 18% year-over-year, and new deal wins in every region,"&nbsp;said Michael Miebach, CEO of Mastercard.&nbsp;"We are driving growth in electronic payments by scaling innovative technologies like tokenization."
Outlook: For the second quarter, Mastercard expects net revenue growth in the&nbsp;high-end of high-single-digits&nbsp;versus the&nbsp;$6.98 billion analyst consensus estimate.&nbsp;
For fiscal 2024, Mastercard projects net revenue growth in the low-end of&nbsp;low-double-digits&nbsp;(prior expectations of high-end of low-double-digits) versus&nbsp;$28.11&nbsp;billion&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">analyst consensus estimate</a>.
Mastercard stock gained 19% in the last 12 months. Investors can gain exposure to the stock via&nbsp;SPDR Select Sector Fund – Financial&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)&nbsp;and&nbsp;IShares U.S. Financial Services ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYG#NYSE">IYG</a>).
Price Action: MA shares are down 1.35% at $445.11 at the last check Wednesday.
Also Read: <a href="https://www.benzinga.com/news/24/04/38181568/mastercard-revamps-structure-for-growth-new-teams-to-drive-core-payments-and-services" target="_blank" rel="noreferrer noopener">Mastercard Revamps Structure for Growth, New Teams to Drive Core Payments and Services</a>
Photo via Wikimedia Commons

Earnings

Guidance

Mastercard Says Consumer Spending Is Healthy, Clocks 10% Revenue Growth In Q1

JP Morgan analyst Richard Choe maintains DigitalBridge Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBRG#NYSE">DBRG</a>) with a Overweight and lowers the price target from $25 to $23.

DBRG

JP Morgan Maintains Overweight on DigitalBridge Gr, Lowers Price Target to $23

Personal finance expert Suze Orman advised the host of CNN's "Who's Talking to Chris Wallace" show that leasing a car is a waste of money, so buying one is better. Here's why.&nbsp;
During her November appearance on the show, Wallace asked <a href="https://www.benzinga.com/personal-finance/24/04/38112723/suze-orman-doesnt-believe-people-are-doing-ok-despite-being-told-the-economy-is-strong-in-my-opi">Orman</a> whether it was better to lease or buy a car and told her that he leases a car. Orman did not hold back, telling Wallace why she believed leasing a car was not a good use of his money. Instead, she believes that buying the car is the better option.&nbsp;
Don't Miss:
<ul>
<li>82% of Americans aren&#8217;t using<a href="https://www.benzinga.com/money/public-hys"> this government secured 5% passive income stream</a>, are you one of them?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/red-ventures"> The percentage may shock you</a>.</li>
</ul>
"Leasing a car is the biggest waste of money out there," she said. "If you keep it the entire time, [for] the life of it, if you take good care of it, [you will save money]. My car is going to be good for another five years. I just think it's better to buy."
This isn't something new from the finance guru, who has reiterated her stance on buying over leasing vehicles over the years. In 2018, Orman appeared on CNBC's financial show "Make It" and explained that with leasing cars, you're pouring money each month into a car that you don't own and when that lease ends, you'll have nothing to show from it.&nbsp;
"If you rent a car, you're going to rent a car year in and year out," she said.&nbsp;
Wallace said leasing makes more sense for people who don't want to deal with older cars and the repairs that come with them. You also can lease a luxury car you may not be able to afford to buy. Leasing also is an attractive option for drivers who want the advanced automotive features new cars offer.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: If the United States had access to<a href="https://www.benzinga.com/money/public-hys-avgamerican"> today&#8217;s high-yield savings accounts rates</a> in 2015, it wouldn&#8217;t need to save another penny.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Another reason Wallace said he prefers leasing over buying is that he gets a new car every three years. Because he never exceeds the leasing mileage limit, his overall payments are less than the payments would be if he financed the vehicle.&nbsp;
Orman disagreed.&nbsp;
"You only get to drive at 12,000 miles," she said. "You have to have a lease gap insurance. Why don't you do what I do? I bought a car."&nbsp;
Orman said buying a used car is best because a vehicle never increases in value, making it a "lousy investment." This means choosing a reliable car over unnecessary bells and whistles.&nbsp;
Leasing a car is attractive to some people because it offers lower or no down payments with less expensive <a href="https://www.benzinga.com/money/how-much-car-can-i-afford-based-on-my-salary">monthly payments for luxury vehicles</a>. Orman understands that leasing is a more financially available option for some people, which is why she said financing a car is the next-best option instead of leasing.&nbsp;
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
<hr class="wp-block-separator has-alpha-channel-opacity" />
When financing a car, Orman said it's important to make sure that you pay it off within three years. If you can't, it's a signal to purchase a cheaper vehicle. In a 2017 blog post, Orman said buyers should spend the least amount possible on a car because paying less will help them pay off the car faster.&nbsp;
Once the car is paid off, Orman advises hanging onto it for as long as possible. She keeps her cars for 12 years, which frees up money to be spent on other things like investments, saving for <a href="https://www.benzinga.com/personal-finance/24/04/38412735/dave-ramsey-against-401k-for-education-your-retirement-savings-come-first-even-before-funding-co">retirement</a> or paying off debts.&nbsp;
Orman said that if you follow her advice and buy a car with a three-year loan instead of leasing, you'll own the vehicle after those 36 months. Depending on your mileage and how well you take care of your car, you could keep driving it for at least another seven years without committing to another loan payment.&nbsp;
While leasing is an option for people seeking cheaper monthly payments, lower down payments and perhaps do not drive as often, buying can put you financially ahead in the long term.&nbsp;
Read Next:
<ul>
<li>Are you secretly doing better with your money than you think?<a href="https://www.benzinga.com/money/money-pickle-financially-healthy"> Here are some signs you&#8217;re financially healthy.</a></li>
<li>Warren Buffett flipped his neighbor's $67,000 life savings into a $50 million fortune —<a href="https://www.benzinga.com/money/advisor-adv-warren-buffett"> How much is that worth today?</a></li>
</ul>

Personal Finance

Suze Orman Calls Car Leasing The 'Biggest Waste Of Money' And Advises To Buy Rather Than Lease

JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Neutral and lowers the price target from $159 to $158.

JP Morgan Maintains Neutral on Clorox, Lowers Price Target to $158

Toyota Motor North America Reported April 2024 U.S. Sales Of 211,818 Vehicles, Up 13.7% On A Volume Basis

IPOs

Viking Holdings IPO Indicating $27/Share; IPO Priced At $24/Share

WIIM

Ryerson Holding shares are trading lower following a Q1 EPS miss.

InfuSystem Holdings: 2024 Will Be A Year Of Monetization

Sanara MedTech reports Q4 results

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Sanara MedTech (NASDAQ:<a href="https://investorplace.com/stock-quotes/smti-stock-quote/">SMTI</a>) just reported results for the fourth quarter of 2023.<ul><li>Sanara MedTech reported earnings per share of -3 cents. This was above the analyst estimate for EPS of -13 cents.</li><li>The company reported revenue of $17.69 million.</li><li>This was 7.21% better than the analyst estimate for revenue of $16.50 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/smti-stock-earnings-sanara-medtech-for-q4-of-2023/">SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023

Sanara MedTech Inc. 2023 Q4 - Results - Earnings Call Presentation

Sanara MedTech Inc. (SMTI) Q4 2023 Earnings Call Transcript

Sanara Medtech Inc (SMTI) said after close Monday that it lost $0.03 per share in quarter four 2023. On the revenue line, the company reported $17.7 million, beating estimates by $1.2 million.In the same quarter a year ago, the company lost $0.51 per share on revenue of $15.3 million. The stock is up 2.07% to $37.00 after

Sanara Medtech Inc Up 2.07% To $37.00 After Earnings Beat

Sanara MedTech (SMTI) has disclosed a new risk, in the Debt & Financing category. Sanara MedTech's financial condition could be significantly compr...

Sanara MedTech's Balancing Act: Navigating High Debt and Competitive Pressures in a Rising Rate Landscape

Sanara MedTech appoints Jake Waldrop as COO and Tyler Palmer as chief corporate development and strategy officer

An update from Sanara MedTech (SMTI) is now available. Sanara MedTech Inc. has announced the appointment of Jacob A. Waldrop as its new Chief Opera...

Sanara MedTech Welcomes Jacob Waldrop as New COO

Sanara MedTech (SMTI) has provided an update. Sanara MedTech Inc. secured a $55 million senior secured term loan with initial borrowing set at $15 ...

Sanara MedTech Secures $55 Million Term Loan with Strategic Conditions

GEHC

INFU

Press Releases

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

Sanara MedTech Inc. Announces Third Quarter 2023 Results

Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing

Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides

Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

Sanara MedTech Inc. Announces $55 Million Debt Facility

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sanara MedTech Stock (NASDAQ:SMTI), Short Interest Report

People Also Watch